Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > "Griproom" article - 10 signs your company is to be acquired

<< Previous

Bullboard Posts

Next >>

Comment by Noteableon Oct 19, 2023 10:26am

94 Views

Post# 35690763

RE:RE:"Griproom" article - 10 signs your company is to be acquired

2. Social media posts are overly bearish and calling for the CEO’s removal.

3. Wild fluctuations in stock price.

6. “Sell this, buy that.”

7. Bizarre price action prior to upcoming milestones.

https://www.griproom.com/fun/10-signs-your-company-is-about-to-be-acquired

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta